Therapeutic Solutions International: Funding & Investors (Sep 2026)
Therapeutic Solutions International is a biotechnology company engaged in the development of products for females. The company offers Vital which helps its users stay active; ProJuvenol, an anti-ageing solution that helps promote cellular rejuvenation and healthy functionality for everyday living; and T-Rx which enables its users to control their levels of estrogen. Therapeutic Solutions International is based in California, United States.
Therapeutic Solutions International has raised $10.0M across 1 funding round on record, the most recent a Post-IPO Equity of $10.0M announced in Sep 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Therapeutic Solutions International Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Therapeutic Solutions International Funding Rounds
Therapeutic Solutions International Founders and Leadership Team
No contact details are on record for this team yet.
Therapeutic Solutions International Funding Compared to Other Biotechnology Startups
Therapeutic Solutions International's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Therapeutic Solutions International in Biotechnology and Oceanside
Companies Similar to Therapeutic Solutions International
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Therapeutic Solutions International Funding FAQs
What does Therapeutic Solutions International do?
Therapeutic Solutions International is a biotechnology company engaged in the development of products for females. The company offers Vital which helps its users stay active; ProJuvenol, an anti-ageing solution that helps promote cellular rejuvenation and healthy functionality for everyday living; and T-Rx which enables its users to control their levels of estrogen. Therapeutic Solutions International is based in California, United States.
How much funding has Therapeutic Solutions International raised?
Therapeutic Solutions International has raised $10.0M across 1 round on record. The most recent is a Post-IPO Equity of $10.0M announced in Sep 2022.
When did Therapeutic Solutions International last raise funding?
Therapeutic Solutions International's most recent funding round on record is a Post-IPO Equity of $10.0M, announced in Sep 2022.
Who is the CEO of Therapeutic Solutions International?
Tim Dixon is listed as CEO at Therapeutic Solutions International.
Where is Therapeutic Solutions International headquartered?
Therapeutic Solutions International is based in Oceanside, California, United States.
How many employees does Therapeutic Solutions International have?
Therapeutic Solutions International is in the 1-10 employee band.
How does Therapeutic Solutions International's funding compare to other Biotechnology startups?
Therapeutic Solutions International's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Therapeutic Solutions International Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Therapeutic Solutions International is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.